HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rhamnogalacturonan II is a Toll-like receptor 4 agonist that inhibits tumor growth by activating dendritic cell-mediated CD8+ T cells.

Abstract
We evaluated the effectiveness of rhamnogalacturonan II (RG-II)-stimulated bone marrow-derived dendritic cells (BMDCs) vaccination on the induction of antitumor immunity in a mouse lymphoma model using EG7-lymphoma cells expressing ovalbumin (OVA). BMDCs treated with RG-II had an activated phenotype. RG-II induced interleukin (IL)-12, IL-1β, tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) production during dendritic cell (DC) maturation. BMDCs stimulated with RG-II facilitate the proliferation of CD8+ T cells. Using BMDCs from the mice deficient in Toll-like receptors (TLRs), we revealed that RG-II activity is dependent on TLR4. RG-II showed a preventive effect of immunization with OVA-pulsed BMDCs against EG7 lymphoma. These results suggested that RG-II expedites the DC-based immune response through the TLR4 signaling pathway.
AuthorsSung Nam Park, Kyung Tae Noh, Young-Il Jeong, In Duk Jung, Hyun Kyu Kang, Gil Sun Cha, Su Jung Lee, Jong Keun Seo, Dae Hwan Kang, Tae-Ho Hwang, Eun Kyung Lee, Byungsuk Kwon, Yeong-Min Park
JournalExperimental & molecular medicine (Exp Mol Med) Vol. 45 Pg. e8 (Feb 08 2013) ISSN: 2092-6413 [Electronic] United States
PMID23392255 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Acute-Phase Proteins
  • Adaptor Proteins, Vesicular Transport
  • Carrier Proteins
  • Cytokines
  • Lipopolysaccharide Receptors
  • Membrane Glycoproteins
  • Myeloid Differentiation Factor 88
  • NF-kappa B
  • Receptors, Chemokine
  • TICAM-1 protein, mouse
  • Toll-Like Receptor 4
  • lipopolysaccharide-binding protein
  • rhamnogalacturonan II
  • Pectins
  • Mitogen-Activated Protein Kinases
Topics
  • Acute-Phase Proteins (metabolism)
  • Adaptor Proteins, Vesicular Transport (metabolism)
  • Animals
  • Bone Marrow Cells (cytology, drug effects)
  • CD8-Positive T-Lymphocytes (immunology)
  • Carrier Proteins (metabolism)
  • Cell Differentiation (drug effects)
  • Cell Nucleus (drug effects, metabolism)
  • Cell Proliferation (drug effects)
  • Cytokines (biosynthesis)
  • Dendritic Cells (cytology, drug effects, enzymology, immunology)
  • Enzyme Activation (drug effects)
  • Lipopolysaccharide Receptors (metabolism)
  • Lymphocyte Activation (drug effects)
  • Membrane Glycoproteins (metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mitogen-Activated Protein Kinases (metabolism)
  • Myeloid Differentiation Factor 88 (metabolism)
  • NF-kappa B (metabolism)
  • Neoplasms (immunology, pathology)
  • Pectins (pharmacology)
  • Phenotype
  • Protein Transport (drug effects)
  • Receptors, Chemokine (metabolism)
  • Signal Transduction (drug effects)
  • T-Lymphocytes, Cytotoxic (cytology, drug effects)
  • Toll-Like Receptor 4 (agonists, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: